Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients (Q39422572)

11 September 2017

title

Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients (English)

1 reference

Human T-lymphotropic virus 1

11 September 2017

main subject

0 references

1 reference

1 reference

Saito M

1

1 reference

11 September 2017

Nakamura N

2

1 reference

11 September 2017

Nagai M

3

1 reference

11 September 2017

Shirakawa K

4

1 reference

11 September 2017

Sato H

5

1 reference

11 September 2017

Kawahigashi N

6

1 reference

11 September 2017

Furukawa Y

7

1 reference

11 September 2017

Usuku K

8

1 reference

11 September 2017

Nakagawa M

9

1 reference

11 September 2017

Izumo S

10

1 reference

11 September 2017

Osame M

11

1 reference

11 September 2017

publication date

1 August 1999

1 reference

Journal of Neuroimmunology

11 September 2017

published in

1 reference

11 September 2017

volume

98

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

221-226

1 reference

A role for CD95 ligand in preventing graft rejection

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Immunological studies in tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

1 reference

7 January 2021

HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900095-8

7 January 2021

10.1016/S0165-5728(99)00095-8

Identifiers

DOI

1 reference

11 September 2017

1 reference